David F. Gebhard

Development of a new permeability assay using low‐efflux MDCKII cells

Li Di, Carrie Whitney‐Pickett, John P. Umland et al. · Journal of Pharmaceutical Sciences · 2011 · 311 citations

Membrane Transport, Membrane Biology, Biomedical Engineering +6

A high content screening assay for identifying lysosomotropic compounds

Sashi Nadanaciva, Shuyan Lu, David F. Gebhard et al. · Toxicology in Vitro · 2010 · 202 citations

Biochemistry, Medicine, Natural Sciences +8

Proline-rich tyrosine kinase 2 regulates osteoprogenitor cells and bone formation, and offers an anabolic treatment approach for osteoporosis

Leonard Buckbinder, David T. Crawford, Hong Qi et al. · Proceedings of the National Academy of Sciences · 2007 · 154 citations · Full text

Sclerostin, Coupled Actions, High Bone Mass +19

Efficient Liver Targeting by Polyvalent Display of a Compact Ligand for the Asialoglycoprotein Receptor

Carlos Sanhueza, Michael M. Baksh, Benjamin A. Thuma et al. · Journal of the American Chemical Society · 2017 · 108 citations · Full text

Drug Target, Medicinal Chemistry, Asialoglycoprotein Receptor +19

Evidence for a terminal differentiation process in the rat liver

Samuel H. Sigal, Sanjeev Gupta, David F. Gebhard et al. · Differentiation · 1995 · 91 citations

Developmental Biology, Hepatology, Biliary Tract +12